Accord Biomaterials

Founded in Arbor, Michigan, Accord Biomaterials is dedicated to advancing medical device protection through innovative chemistries and coatings. The company’s core mission is to enhance the safety and efficacy of blood-contacting medical devices by developing catalytic nitric oxide coatings that mitigate complications such as clotting and altered healing. Accord Biomaterials focuses on providing cutting-edge solutions to the medical device industry, aiming to improve patient outcomes and device performance.

Notable figures affiliated with Accord Biomaterials include leading scientists and engineers specializing in biomedical materials. The company has attracted investment from key players in the healthcare and medical device sectors, underscoring its potential for significant impact. Among its achievements, Accord has successfully developed proprietary nitric oxide coatings that have shown promising results in preclinical trials. Overall, Accord Biomaterials is poised to make a substantial impact on the medical device market by addressing critical challenges in device safety and functionality.